evaluate the supplements company replenza on glp 1 GLP-1 Support Daily Replenisher, Lemon Review of Replenza GLP-1 Support:

Oral GLP-1s for obesity saw a recent setback when in April (April 2025), Pfizer announced that it was discontinuing development of danuglipron, an oral GLP-1 receptor agonist, which was being investigated for chronic weight management, due to potential liver toxicity

-L- (Thorne) ,

We thank Home for Researchers editorial team (www.home-for-researchers.com) for language editing service

Recalls & Warnings January 15, 2026 Super Greens Supplement Powders Linked to Salmonella Outbreak On January 14, 2026, the FDA warned consumers not to use Live It Up Super Greens powder (Original and Wild Berry flavors) with expiration dates from 08/2026 to 01/2028, because it has been linked with a multistate outbreak of Salmonella illness

Higher GBB levels were also associated with increased risk ofand poorer survival frommajor cardiovascular events (death, myocardial infarction, or stroke), but only when TMAO levels were also elevated.14 Continuing along the carnitine metabolism pathway to the liver, individual genetic variation may play a role in elevated TMAO levels by increasing conversion of TMA to TMAO by the enzyme flavin-containing monooxygenase 3 (FMO3)